(Q34434824)

2 August 2017

1 reference

title

Fever following immunization (English)

1 reference

2 August 2017

0 references

2

Ulrich Heininger

1 reference

2 August 2017

Terhi Tapiainen

1

1 reference

2 August 2017

1 June 2005

1 reference

Expert Review of Vaccines

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

3

1 reference

2 August 2017

419-427

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

2 August 2017

1 reference

Pyrogen sensing and signaling: old views and new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Temperature measured at the axilla compared with rectum in children and young people: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Fever phobia revisited: have parental misconceptions about fever changed in 20 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Physicians' attitudes toward the diagnosis and management of fever in children 3 months to 2 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Fever: beneficial and detrimental effects of antipyretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

An open randomized controlled trial of infection prevention in child day-care centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Pneumococcal vaccine campaign based in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

The effectiveness of vaccination against influenza in healthy, working adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Characterization of measles viruses isolated after measles vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Detection of measles vaccine in the throat of a vaccinated child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Risk factors for a first febrile seizure: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Necrotizing fasciitis associated with injection drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Reporting of vaccine safety data in publications: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

The Brighton Collaboration: enhancing comparability of vaccine safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

Unexplained fever in young children: how to manage severe bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

MMR Vaccination and Febrile Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.419

21 January 2018

Identifiers

DOI

10.1586/14760584.4.3.419

1 reference

2 August 2017

1 reference

PubMed ID

16026253